Editorial: The World Health Organization (WHO) Fungal Priority Pathogens List in Response to Emerging Fungal Pathogens During the COVID-19 Pandemic

Related articles

24 Jan 2024 : Clinical Research

Impact of COVID-19 Lockdown on Traumatic Bone Fracture Patterns and Hospital Outcomes in 1646 Elderly Patients: A Retrospective Study in Turkey

Ahmet Akif Durak , Mehmet Ergin , [...] Selahattin Gürü , Hakan Oğuztürk , Gulhan Kurtoglu Celik , Servan Gökhan , Mehmet Ali Ceyhan  - Show fewer authors

DOI: 10.12659/MSM.942916

01 Dec 2023 : Editorial

Editorial: Outbreaks of Post-Pandemic Childhood Pneumonia and the Re-Emergence of Endemic Respiratory Infections

Dinah V. Parums,

DOI: 10.12659/MSM.943312

01 Jul 2023 : Editorial

Editorial: Post-Acute Sequelae of SARS-CoV-2 Infection (PASC). Updated Terminology for the Long-Term Effects of COVID-19

Dinah V. Parums,

DOI: 10.12659/MSM.941595

01 Nov 2023 : Editorial

Editorial: Factors Driving New Variants of SARS-CoV-2, Immune Escape, and Resistance to Antiviral Treatments as the End of the COVID-19 Pandemic is Declared

Dinah V. Parums,

DOI: 10.12659/MSM.942960

01 Jan 2022 : Editorial

Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Patients

Dinah V. Parums,

DOI: 10.12659/MSM.935952

01 Feb 2022 : Editorial

Editorial: The 2022 World Health Organization (WHO) Priority Recommendations and Response to the Omicron Variant (B.1.1.529) of SARS-CoV-2

Dinah V. Parums,

DOI: 10.12659/MSM.936199

01 Mar 2022 : Editorial

Editorial: First Approval of the Protein-Based Adjuvanted Nuvaxovid (NVX-CoV2373) Novavax Vaccine for SARS-CoV-2 Could Increase Vaccine Uptake and Provide Immune Protection from Viral Variants

Dinah V. Parums,

DOI: 10.12659/MSM.936523

01 May 2022 : Editorial

Editorial: Cardiovascular Complications at One Year After SARS-CoV-2 Infection are Independent of Underlying Cardiovascular Risk Factors or Severity of COVID-19

Dinah V. Parums,

DOI: 10.12659/MSM.937048

01 Jul 2022 : Editorial

Editorial: World Health Organization (WHO) Variants of Concern Lineages Under Monitoring (VOC-LUM) in Response to the Global Spread of Lineages and Sublineages of Omicron, or B.1.1.529, SARS-CoV-2

Dinah V. Parums,

DOI: 10.12659/MSM.937676

01 Aug 2022 : Editorial

Editorial: Long-Term Effects of Symptomatic and Asymptomatic SARS-CoV-2 Infection in Children and the Changing Pathogenesis of Common Childhood Viruses Driven by the COVID-19 Pandemic

Dinah V. Parums,

DOI: 10.12659/MSM.937927

01 Oct 2022 : Editorial

Editorial: Rebound COVID-19 and Cessation of Antiviral Treatment for SARS-CoV-2 with Paxlovid and Molnupiravir

Dinah V. Parums,

DOI: 10.12659/MSM.938532

06 Sep 2021 : Editorial

Editorial: First Full Regulatory Approval of a COVID-19 Vaccine, the BNT162b2 Pfizer-BioNTech Vaccine, and the Real-World Implications for Public Health Policy

Dinah V. Parums,

DOI: 10.12659/MSM.934625

20 Sep 2021 : Editorial

Editorial: Autoantibodies to Components of the Immune System, Including Type 1 Interferons, and the Risk of Severe COVID-19

Dinah V. Parums,

DOI: 10.12659/MSM.934766

04 Oct 2021 : Editorial

Editorial: A Decline in Influenza During the COVID-19 Pandemic and the Emergence of Potential Epidemic and Pandemic Influenza Viruses

Dinah V. Parums,

DOI: 10.12659/MSM.934949

11 Oct 2021 : Editorial

Editorial: Multisystem Inflammatory Syndrome in Adults (MIS-A) and the Spectrum of COVID-19

Dinah V. Parums,

DOI: 10.12659/MSM.935005

18 Oct 2021 : Editorial

Editorial: Global Initiatives Support the Use and Regulation of Digital Health Technology During the COVID-19 Pandemic

Dinah V. Parums,

DOI: 10.12659/MSM.935123

01 Nov 2021 : Editorial

Editorial: What Can be Learned from National and International Vaccine Adverse Event Reporting Systems During the COVID-19 Pandemic?

Dinah V. Parums,

DOI: 10.12659/MSM.935299

26 Apr 2021 : Editorial

Editorial: SARS-CoV-2 mRNA Vaccines and the Possible Mechanism of Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT)

Dinah V. Parums,

DOI: 10.12659/MSM.932899

01 Dec 2021 : Editorial

Editorial: SARS-CoV-2 Vaccine Responses and Breakthrough COVID-19

Dinah V. Parums,

DOI: 10.12659/MSM.935624

10 May 2021 : Editorial

Editorial: The Pathogenesis of Long-Term Neuropsychiatric COVID-19 and the Role of Microglia, Mitochondria, and Persistent Neuroinflammation: A Hypothesis

George B. Stefano, Pascal Büttiker, [...] Simon Weissenberger, Anders Martin, Radek Ptacek, Richard M. Kream - Show fewer authors

DOI: 10.12659/MSM.933015

31 May 2021 : Editorial

Editorial: COVID-19 and Multisystem Inflammatory Syndrome in Children (MIS-C)

Dinah V. Parums,

DOI: 10.12659/MSM.933369

07 Jun 2021 : Editorial

Editorial: Long COVID, or Post-COVID Syndrome, and the Global Impact on Health Care

Dinah V. Parums,

DOI: 10.12659/MSM.933446

21 Jun 2021 : Editorial

Editorial: Revised World Health Organization (WHO) Terminology for Variants of Concern and Variants of Interest of SARS-CoV-2

Dinah V. Parums,

DOI: 10.12659/MSM.933622

05 Jul 2021 : Editorial

Editorial: Maternal SARS-CoV-2 Infection and Pregnancy Outcomes from Current Global Study Data

Dinah V. Parums,

DOI: 10.12659/MSM.933831

19 Jul 2021 : Editorial

Editorial: Tocilizumab, a Humanized Therapeutic IL-6 Receptor (IL-6R) Monoclonal Antibody, and Future Combination Therapies for Severe COVID-19

Dinah V. Parums,

DOI: 10.12659/MSM.933973

02 Aug 2021 : Editorial

Editorial: The National COVID Cohort Collaborative Consortium Combines Population Data with Machine Learning to Evaluate and Predict Risk Factors for the Severity of COVID-19

Dinah V. Parums,

DOI: 10.12659/MSM.934171

16 Aug 2021 : Editorial

Editorial: Post-Exposure Prophylactic Neutralizing Monoclonal Antibodies to SARS-CoV-2 for Individuals at High Risk for COVID-19

Dinah V. Parums,

DOI: 10.12659/MSM.934393

30 Aug 2021 : Editorial

Editorial: Reporting Clinical Trials with Important Modifications Due to Extenuating Circumstances, Including the COVID-19 Pandemic: CONSERVE 2021

Dinah V. Parums,

DOI: 10.12659/MSM.934514